MedPharm and Molecular Profiles form alliance

Published: 21-Aug-2012
Manufacturing Regulatory Finance

To enhance clinical trial material manufacturing capabilities


MedPharm and Molecular Profiles have formed a dedicated topical medicine manufacturing service for clinical trial material.

The UK firms will provide small-scale clinical trial supplies, including more complex new chemical entities (NCEs), to help customers get to proof of concept in clinical trials (Phase II) as early as possible.

No financial details were revealed.

Guildford, Surrey-based MediPharm’s ceo Andrew Muddle said the partnership would allow the firm to offer an expanded range of GMP services to customers.

Nikin Patel, ceo of Molecular Profiles, which is based in Nottingham, added that the alliance with MedPharm ‘is an opportunity for both companies to expand our service offerings within topical drug delivery’.

  • Companies:
  • Medpharm
  • Juniper Pharma Services
See more

You may also like

Manufacturing

MedPharm and Tergus Pharma join forces to form topical and transepithelial CDMO

Read more
The two CDMOs will collaborate to provide end-to-end development and manufacturing services in the topical and transepithelial pharmaceutical sector — including high-potency, hormone-based drugs

Trending Articles

  1. Sartorius Stedim Biotech supports bioprocess development with new Innovation Centre The Massachusetts, US-based Centre for Bioprocess Innovation is a collaborative space designed to develop and optimise biomanufacturing processes
  2. IMed Consultancy helps Toby Orthopaedics navigate UK regulations Regulatory consultancy ensures compliance and confidence for Miami-based company
  3. Aurobindo Pharma signs $25m respiratory drug development and commercialisation deal with global pharma company The companies will co-develop and commercialise respiratory therapeutics, diversifying Aurobindo's current portfolio
  4. IMed supports K2 medical systems in their EU MDR transition Consultancy firm helps K2 navigate the complex regulatory process to achieve Article 97 compliance

Upcoming event

CPhI Middle East

10–12 December 2024 | Conference | Riyadh, Saudi Arabia See all

You may also like

Manufacturing

MedPharm and Tergus Pharma join forces to form topical and transepithelial CDMO

The two CDMOs will collaborate to provide end-to-end development and manufacturing services in the topical and transepithelial pharmaceutical sector — including high-potency, hormone-based drugs
Manufacturing

Manufacturing Chemist LIVE announces NEPIC as an event partner

NEPIC members are invited to attend or exhibit at this year's event at a discounted rate.
Manufacturing

Medpharm opens North Carolina manufacturing facility

The facility is designed to meet all FDA, EMA and GMP requirements in its operational support systems, technology and resource management
Manufacturing

The MC roundtable: how CDMOs are responding to pharma’s top priorities in 2021 (part III)

Dr Kevin Robinson held a virtual roundtable with representatives from a number of top-tier contract (development and) manufacturing organisations (CMOs/CDMOs), including Pfizer CentreOne, Samsung Biologics, MedPharm, Metrics Contract Services, Vibalogics and Sterling Pharma Solutions, to discuss the pressing issues in the pharmaceutical outsourcing sector
Manufacturing

The MC roundtable: how CDMOs are responding to pharma’s top priorities in 2021 (part II)

Dr Kevin Robinson held a virtual roundtable with representatives from a number of top-tier contract (development and) manufacturing organisations (CMOs/CDMOs), including Pfizer CentreOne, Samsung Biologics, MedPharm, Metrics Contract Services, Vibalogics and Sterling Pharma Solutions, to discuss the pressing issues in the pharmaceutical outsourcing sector
Manufacturing

The MC roundtable: how CDMOs are responding to pharma’s top priorities in 2021 (part I)

Dr Kevin Robinson held a virtual roundtable with representatives from a number of top-tier contract (development and) manufacturing organisations (CMOs/CDMOs), including Pfizer CentreOne, Samsung Biologics, MedPharm, Metrics Contract Services, Vibalogics and Sterling Pharma Solutions, to discuss the pressing issues in the pharmaceutical outsourcing sector
Regulatory

MedPharm completes successful FDA inspection at US centre of excellence

The inspection coincides with the recent expansion of MedPharm's facilities to triple its footprint and accommodate up to 100 employees in the future
Subscribe now